Dr. Martens (DOCS) Competitors GBX 54.85 -1.00 (-1.79%) (As of 08:28 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades DOCS vs. RMG, TEM, GEN, SPT, YOU, WIX, CNIC, SST, API, and SRADShould you be buying Dr. Martens stock or one of its competitors? The main competitors of Dr. Martens include Royal Mail (RMG), Templeton Emerging Markets Investment Trust (TEM), Genuit Group (GEN), Spirent Communications (SPT), YouGov (YOU), Wickes Group (WIX), CentralNic Group (CNIC), Scottish Oriental Smaller Cos (SST), abrdn Property Income Trust (API), and Stelrad Group (SRAD). These companies are all part of the "computer software" industry. Dr. Martens vs. Royal Mail Templeton Emerging Markets Investment Trust Genuit Group Spirent Communications YouGov Wickes Group CentralNic Group Scottish Oriental Smaller Cos abrdn Property Income Trust Stelrad Group Dr. Martens (LON:DOCS) and Royal Mail (LON:RMG) are both small-cap consumer cyclical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment. Do institutionals and insiders believe in DOCS or RMG? 69.5% of Dr. Martens shares are owned by institutional investors. 4.4% of Dr. Martens shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is DOCS or RMG more profitable? Dr. Martens has a net margin of 7.89% compared to Royal Mail's net margin of 0.00%. Dr. Martens' return on equity of 17.92% beat Royal Mail's return on equity.Company Net Margins Return on Equity Return on Assets Dr. Martens7.89% 17.92% 8.12% Royal Mail N/A N/A N/A Does the media refer more to DOCS or RMG? In the previous week, Dr. Martens had 1 more articles in the media than Royal Mail. MarketBeat recorded 2 mentions for Dr. Martens and 1 mentions for Royal Mail. Dr. Martens' average media sentiment score of 0.38 beat Royal Mail's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dr. Martens 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Royal Mail 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, DOCS or RMG? Dr. Martens has higher earnings, but lower revenue than Royal Mail. Royal Mail is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDr. Martens£877.10M0.60£69.20M£0.07783.57Royal Mail£12.71B0.16N/A£0.61339.34 Does the MarketBeat Community prefer DOCS or RMG? Royal Mail received 513 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 54.30% of users gave Royal Mail an outperform vote. CompanyUnderperformOutperformDr. MartensOutperform Votes1191.67% Underperform Votes18.33%Royal MailOutperform Votes52454.30% Underperform Votes44145.70% Is DOCS or RMG a better dividend stock? Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.5%. Royal Mail pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.1%. Dr. Martens pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Royal Mail pays out 27.4% of its earnings in the form of a dividend. SummaryDr. Martens beats Royal Mail on 11 of the 15 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Dr. Martens News Delivered to You Automatically Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOCS vs. The Competition Export to ExcelMetricDr. MartensFootwear & Accessories IndustryCyclical SectorLON ExchangeMarket Cap£527.50M£9.09B£2.37B£1.39BDividend Yield4.63%3.50%4.38%11.73%P/E Ratio783.5792.66383.631,549.53Price / Sales0.6021.07360.17209,150.30Price / Cash14.2941.2225.1632.93Price / Book1.442.983.092.80Net Income£69.20M£169.65M£257.93M£152.70M7 Day Performance-4.94%-1.07%-0.94%-0.55%1 Month Performance1.01%-1.10%-2.76%7.05%1 Year Performance-51.59%0.64%11.82%91.75% Dr. Martens Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOCSDr. MartensN/AGBX 54.85-1.8%N/A-51.8%£527.50M£877.10M783.57890Dividend CutGap UpRMGRoyal MailN/AGBX 207+5.4%N/A+0.0%£1.98B£12.71B339.34100TEMTempleton Emerging Markets Investment TrustN/AGBX 164.60-0.2%N/A+9.3%£1.76B£173.08M1,378.33N/AGENGenuit Group1.9014 of 5 starsGBX 392+1.0%GBX 512.50+30.7%+26.0%£976.75M£554.10M3,880.002,700SPTSpirent Communications2.224 of 5 starsGBX 169.76-0.4%GBX 253.33+49.2%+58.5%£970.78M£447.70M8,525.001,526YOUYouGov3.3273 of 5 starsGBX 425-0.7%GBX 905+112.9%-59.2%£496.27M£270M2,140.001,820WIXWickes Group2.7236 of 5 starsGBX 148.62+0.3%GBX 180+21.1%+12.3%£352.36M£1.53B1,235.005,930Gap DownCNICCentralNic GroupN/AGBX 123.20+2.0%N/A-1.3%£339.82M£790.04M-12,660.00100SSTScottish Oriental Smaller CosN/AGBX 1,414.97+0.7%N/A+12.4%£333.23M£53.86M841.32320Dividend IncreasePositive NewsAPIabrdn Property Income TrustN/AGBX 60.60+0.2%N/A+23.0%£231.02M£32.44M-3,022.501,310SRADStelrad GroupN/AGBX 138.10-2.4%N/A+38.7%£175.87M£294.27M1,150.002,960 Related Companies and Tools Related Companies Royal Mail Alternatives Templeton Emerging Markets Investment Trust Alternatives Genuit Group Alternatives Spirent Communications Alternatives YouGov Alternatives Wickes Group Alternatives CentralNic Group Alternatives Scottish Oriental Smaller Cos Alternatives abrdn Property Income Trust Alternatives Stelrad Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:DOCS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
